Revolution Medicines, Inc.
RVMD
Helyezés a részvények között
#619
Revolution Medicines, Inc. is a precision oncology firm operating in the... Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic arsenal, Revolution Medicines is advancing RMC-6291, which selectively inhibits mutated forms of KRASG12C(ON) and NRASG12C(ON). Another promising compound, RMC-6236, specifically targets and inhibits a range of active RAS(ON) variants. Its research efforts also encompass other active RAS inhibitors aimed at KRASG13C(ON) and KRASG12D(ON) mutations. Revolution Medicines has established a collaborative partnership with Sanofi to research and develop SHP2 inhibitors, a collaboration that includes the development of RMC-4630. Established in 2014, Revolution Medicines, Inc. operates from its corporate headquarters situated in Redwood City, California.
Részvényárfolyam
$182.91
Utolsó szinkronizálás: 2026-10-19
Piaci kapitalizáció
$39.20B
Változás (1 nap)
2.78%
Változás (1 év)
238.66%
Ország
US
Kereskedés Revolution Medicines, Inc. (RVMD)
Kategória
Healthcare
EPS Revolution Medicines, Inc. (RVMD) részvényre
EPS June 2026 dátummal, TTM: $-8.86
Revolution Medicines, Inc. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $-8.86. 2023 végén a vállalat EPS mutatója $-3.86 volt, növekedés a 2022 év EPS értékéhez, amely $-3.08 volt.
Revolution Medicines, Inc. EPS története 2017 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $-8.86 | 147.49% |
| 2024 | $-3.58 | -7.25% |
| 2023 | $-3.86 | 25.32% |
| 2022 | $-3.08 | 24.70% |
| 2021 | $-2.47 | 52.47% |
| 2020 | $-1.62 | 23.66% |
| 2019 | $-1.31 | 13.91% |
| 2018 | $-1.15 | 35.29% |
| 2017 | $-0.85 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| $17.32 | -295.49% |
US
|
|
| $-7.98 | -9.93% |
US
|
|
| $-5.29 | -40.29% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -413.09% |
NL
|
